Related references
Note: Only part of the references are listed.Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
D. M. Daugla et al.
LANCET (2014)
The impact of protein-conjugate polysaccharide vaccines: an endgame for meningitis?
Martin C. J. Maiden
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2013)
Meningococcal carriage in the African meningitis belt
Oumer Ali et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2013)
Protein carriers of conjugate vaccines Characteristics, development, and clinical trials
Michael E. Pichichero
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2013)
Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000
Li Liu et al.
LANCET (2012)
Development of a group A meningococcal conjugate vaccine, MenAfriVac™
Carl E. Frasch et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Maintaining protection against invasive bacteria with protein-polysaccharide conjugate vaccines
Andrew J. Pollard et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Share Paper
